Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,396
Closed -$252K 253
2024
Q2
$252K Buy
+3,396
New +$255K 0.07% 206
2023
Q2
Sell
-18,514
Closed -$1.49M 259
2023
Q1
$1.49M Buy
18,514
+15,262
+469% +$1.23M 0.54% 35
2022
Q4
$243K Sell
3,252
-833
-20% -$59.3K 0.09% 202
2022
Q3
$264K Sell
4,085
-15,568
-79% -$1.08M 0.1% 185
2022
Q2
$1.36M Buy
19,653
+7,596
+63% +$564K 0.36% 55
2022
Q1
$926K Buy
12,057
+4,242
+54% +$305K 0.2% 151
2021
Q4
$598K Buy
+7,815
New +$574K 0.1% 218

Other funds holding HOLX

Donoghue Forlines's HOLX Position: Q3 2024 in Review

Donoghue Forlines sold out of Hologic (HOLX) in Q3 2024, closing a stake of 3,396 shares — an estimated $252K sold.

Donoghue Forlines first reported a position in HOLX in Q4 2021 and held it in 7 quarters. The position peaked at $1.49M in Q1 2023. 727 funds tracked by Wall St. Rank hold HOLX as of Q3 2024.

  • Donoghue Forlines reported no remaining Hologic position as of Q3 2024 after selling out during the quarter.
  • Donoghue Forlines sold 3,396 Hologic shares in Q3 2024, an estimated $252K.
  • Donoghue Forlines first reported a position in Hologic in Q4 2021 and held it in 7 quarters.
  • Donoghue Forlines's Hologic position peaked at $1.49M in Q1 2023.
  • 727 funds tracked by Wall St. Rank held Hologic as of Q3 2024.

Based on Donoghue Forlines's 13F filing for Q3 2024, filed 13 Nov 2024.